Skip to main content Accessibility help
×
Home
Hostname: page-component-78bd46657c-fstz4 Total loading time: 0.349 Render date: 2021-05-06T22:46:45.227Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }

Preventive strategies in depression: gathering evidence for risk factors and potential interventions

Published online by Cambridge University Press:  02 January 2018

Michael Berk
Affiliation:
Deakin University, School of Medicine and Barwon Health, Geelong, Mental Health Research Institute, Parkville, University of Melbourne, Department of Psychiatry, Parkville, and Orygen Youth Health Research Centre, Parkville, Australia
Felice Jacka
Affiliation:
Deakin University, School of Medicine and Barwon Health, Geelong, Mental Health Research Institute, Parkville, University of Melbourne, Department of Psychiatry, Parkville, and Orygen Youth Health Research Centre, Parkville, Australia
Corresponding
Rights & Permissions[Opens in a new window]

Summary

This editorial critiques the recent literature concerning both vitamin D deficiency in major depression and supplementation as a treatment strategy, and contextualises it within a broader approach to the prevention of depression, based on the recent evidence for lifestyle as a risk factor for depression and anxiety.

Type
Editorials
Copyright
Copyright © Royal College of Psychiatrists, 2012 

Psychiatry has, to date, lacked a clear evidence base regarding modifiable risk factors for depression and, as a consequence, has been unable to adequately address primary prevention strategies. The discipline has thus focused its attentions on the treatment of established disorders and neglected preventive public health approaches targeting the role of modifiable risk factors. Yet the imperative to increase efforts to prevent depression at a population level is clear.

Although unipolar depression is not officially categorised as a non-communicable disease, the World Health Organization has identified it as the illness accounting for the largest burden of disease in middle- and high-income countries, exceeding that of ischaemic heart disease. However, although lifestyle determinants of other non-communicable diseases have been recognised for decades, surprisingly, the link between environment and lifestyle and risk for psychopathology is a very recent discovery (e.g. Akbaraly et al, Reference Akbaraly, Brunner, Ferrie, Marmot, Kivimaki and Singh-Manoux1 Pasco et al, Reference Pasco, Williams, Jacka, Ng, Henry and Nicholson2 Lucas et al Reference Lucas, Mekary, Pan, Mirzaei, O'Reilly and Willett3 ).

Vitamin D and depression

One potentially influential factor is 25-hydroxyvitamin D (25(OH)D). There is now a substantial body of evidence linking low levels of serum 25(OH)D to depressive symptoms, paralleling the other health risks from low vitamin D status, such as osteoporosis and cancer. Given that vitamin D is the most prevalent deficiency in developed societies, the report by Kjærgaard and colleagues in this issue of the Journal is of considerable public health importance. Reference Kjærgaard, Waterloo, Wang, Almås, Figenschau and Hutchinson4 The study had two aims: first, to examine the relationship between those with low or high serum 25(OH)D levels regarding depressive symptoms; and second, to study, in the subgroup of individuals with low levels of 25(OH)D, the impact of supplementation with 40 000 IU vitamin D3/week for 6 months on depressive symptoms. The study succeeded in demonstrating that individuals with low baseline 25(OH)D levels had higher depression scores than those with higher 25(OH)D levels. However, supplementation was of no benefit in addressing depressive symptoms.

Vitamin D has many functions that overlap with the known pathophysiology of depression, which supports the plausibility of a causal role. Vitamin D 25-hydroxylase and 25D-1α-hydroxylase are expressed in brain areas such as the hypothalamus, cerebellum, substantia nigra and retina. Vitamin D has a role in sleep and circadian rhythms, and circadian disruption is well documented in depression. Reference Turek5 In animal models there is cross-talk between glucocorticoids and vitamin D in the hippocampus; Reference Obradovic, Gronemeyer, Lutz and Rein6 dysregulated glucocorticoid signalling is also a core component of depression. Vitamin D also influences neuronal growth, cell proliferation in the developing brain and embryogenesis. Reference Eyles, Burne and McGrath7

Evaluating nutritional treatments

Well-designed negative studies are important to publish, as they may put to bed hot clinical questions. Since three studies have found a significant effect of high-dose vitamin D supplementation on depressive symptoms, Reference Lansdowne and Provost8Reference Vieth, Kimball, Hu and Walfish10 while two others were negative, Reference Kjærgaard, Waterloo, Wang, Almås, Figenschau and Hutchinson4,Reference Sanders, Stuart, Williamson, Jacka, Dodd and Nicholson11 further studies are needed to establish whether there is a causal relation between vitamin D status and symptoms of depression, what confounding influence physical symptoms might have and, finally, to determine whether correcting vitamin D status makes any difference. There are substantive differences between treatment and pathophysiology of symptoms and threshold clinical disorders, and this is likely to hold true for vitamin D as well; biological treatments tend to be more useful in threshold disorders and studies will need to examine interventions independently in each group.

Depression therapy is a methodologically treacherous sea to navigate, and Kjærgaard et al's trial illuminates many of the difficulties inherent in the quest. Addressing a single risk factor, which individually accounts for a small percentage of the variance of a complex disorder with many risk factors, allows for a limited scope for change. The use of antidepressants may be a marker of illness acuity; excluding those with prior treatment may leave only a mildly ill group who, based on our understanding of placebo effects in other clinical trials, would bias the sample to have a high placebo response rate and a low likelihood of response to active therapy. That this study examined a non-clinical sample, where treatment effects are less likely, may have reduced the likelihood of success. Last, a cut-off 25(OH)D level of 55 nmol/l is quite high, and may not reflect overt clinical deficiency. A signal, if there is any, may lie in individuals with more severe deficiency. As an example, a recent intervention study of folic acid and vitamin B12 for the prevention of late-life depression excluded those with severe depression and/or clinically significant vitamin deficiencies on ethical grounds. Reference Walker, Mackinnon, Batterham, Jorm, Hickie and McCarthy12 Although understandable, this is methodologically problematic, as one would not expect to see an impact of vitamin supplementation on those who were not deficient to start with.

The difficulties in evaluating the impact of vitamin D supplementation on depression apply to all nutritional supplementation in a clinical context. An important consideration when inferring causality in any research examining nutritional status against disease outcomes are the metabolic and behavioural effects of acute illness; in individuals with mental illness, nutrient deficiencies can be caused by the disorder itself. Clearly appetite and self-care are altered in a depressed state. Germane to vitamin D, illness can reduce physical activity and hence sun exposure. Reference Bauer, Glenn, Alda, Andreassen, Ardau and Bellivier13 Moreover, stress and acute illness result in significant alterations in nutrient homeostasis, and reduced concentrations of particular nutrients in serum or tissue are observed in those with acute depressive illnesses in the absence of differences in dietary consumption.

In adults with acute illnesses, such as mood disorders, there is a decrease in concentrations of vitamin E, C and A, retinol-binding protein, total lipids, pyridoxal-5′-phosphate and albumin, alongside a simultaneous increase in C-reactive protein levels. The inflammatory response is accompanied by an increase in oxidative stress, due to either increased free radical production or inefficient antioxidant systems, which in turn leads to increased lipid peroxidation. Increased oxidative stress is a pathway by which levels of lipids in membranes may be reduced in the presence of depressive illness, amplifying any pre-existing deficiency. This may very well account for the consistent reports of omega-3 fatty acid deficiency in individuals with acute depressive illness. This is supported by the evidence that omega-3 fatty acids are only useful in those with severe depression, where levels are likely to be reduced as a result of illness, and are of no evident protective utility in the general population. Decreases in serum zinc and folate are also seen in patients with major depression, potentially being secondary to the inflammatory response. Indeed, some studies have reported that the resolution of a depressive episode is accompanied by an increase in serum zinc, in the absence of supplementation. What remains to be established is the efficacy of manipulation of the whole diet, as opposed to supplementation of dietary insufficiency. Although there is some, albeit weak, evidence for folate and omega-3 supplementation in depression, the use of other supplements remains unclear. The relative benefits of supplements as opposed to sun exposure are not established.

Lifestyle and depression

Although many somatic illnesses increase the risk for depression by increasing pain and disability, it is now clear that there are also shared pathophysiological and behavioural risk factors that directly contribute to both somatic and depressive illnesses, including inflammation and oxidative stress. Reference Pasco, Nicholson, Williams, Jacka, Henry and Kotowicz14 Lifestyle plays an important role in determining levels of inflammation; consumption of a Mediterranean-style diet, rich in antioxidants, vitamins, minerals and fibre, is associated with reduced systemic inflammation, whereas unhealthy dietary patterns, now common in both low- and middle-income countries and high-income countries, are associated with increased systemic inflammation. The synergistic interactions between the multitudinous components of diet mean that focusing only on individual nutrients may obscure the true associations between diet and mental health. Thus, an examination of the whole diet has greater utility in examining the nutrition–mental health connection. Reference Akbaraly, Brunner, Ferrie, Marmot, Kivimaki and Singh-Manoux1,Reference Jacka, Pasco, Mykletun, Williams, Hodge and O'Reilly15,Reference Sanchez-Villegas, Delgado-Rodriguez, Alonso, Schlatter, Lahortiga and Majem16 Similarly, physical activity is associated with reduced markers of systemic inflammation and may have direct anti-inflammatory effects, while smoking potently increases inflammation and oxidative stress. Another consequence of poor lifestyle practices is obesity, which is a pro-inflammatory state. Obesity and depression share a bidirectional relationship, with obesity potentially contributing to depression via increasing the level of circulating pro-inflammatory cytokines, and depression predisposing to the accumulation of excess adipose tissue. Thus, many of the same pathways whereby poor lifestyle practices contribute to the high-prevalence non-communicable somatic illnesses also appear to influence the risk and progression of common psychiatric illnesses.

While not discounting the possibility of other shared factors, such as genetics, this rapidly developing evidence base suggests that mental and physical illnesses and lifestyle form a triad, with lifestyle as a common denominator. This opens the door to common and integrated treatment approaches based on these shared pathways. It also affords the potential for novel preventive and treatment strategies for these disorders that are the major contributor to the global burden of disease. Given the success of prevention strategies in reducing cardiovascular disease in many countries, this is the next threshold for mental health. Suggested priority actions overlap with those for non-communicable diseases and include government policies to improve the food and built environments and greater funding for prevention programmes.

Footnotes

See pp. 360-368, this issue.

Declaration of interest

M.B. has received grant/research support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, the National Health and Medical Research Council (NHMRC), Beyond Blue, Rotary Health, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma and Servier, has been a speaker for and/or consultant to Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay and Wyeth. F.J. has received grant/research support from the Brain and Behaviour Research Institute, NHMRC, Australian Rotary Health, the Geelong MedicalResearch Foundation, the Ian Potter Foundation, Eli Lilly and The University of Melbourne and has been a paid speaker for Sanofi-Synthelabo, Janssen Cilag, Servier, Pfizer, Health Ed, Network Nutrition and Eli Lilly. She is currently supported by an NHMRC Fellowship (#628912).

References

1 Akbaraly, TN, Brunner, EJ, Ferrie, JE, Marmot, MG, Kivimaki, M, Singh-Manoux, A. Dietary pattern and depressive symptoms in middle age. Br J Psychiatry 2009; 195: 408–13.CrossRefGoogle ScholarPubMed
2 Pasco, JA, Williams, LJ, Jacka, FN, Ng, F, Henry, MJ, Nicholson, GC, et al. Tobacco smoking as a risk factor for major depressive disorder: population based study. Br J Psychiatry 2008; 193: 322–6.CrossRefGoogle ScholarPubMed
3 Lucas, M, Mekary, R, Pan, A, Mirzaei, F, O'Reilly, EJ, Willett, WC, et al. Relation between clinical depression risk and physical activity and time spent watching television in older women: a 10-year prospective follow-up study. Am J Epidemiol 2011; 174: 1017–27.CrossRefGoogle ScholarPubMed
4 Kjærgaard, M, Waterloo, K, Wang, CEA, Almås, B, Figenschau, Y, Hutchinson, MS, et al. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case.control study and randomised clinical trial. Br J Psychiatry 2012; 201: 360–8.CrossRefGoogle ScholarPubMed
5 Turek, FW. From circadian rhythms to clock genes in depression. Int Clin Psychopharmacol 2007; 22 (suppl 2): S18.CrossRefGoogle ScholarPubMed
6 Obradovic, D, Gronemeyer, H, Lutz, B, Rein, T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2006; 96: 500–9.CrossRefGoogle ScholarPubMed
7 Eyles, D, Burne, T, McGrath, J. Vitamin D in fetal brain development. Semin Cell Dev Biol 2011; 22: 629–36.CrossRefGoogle ScholarPubMed
8 Lansdowne, AT, Provost, SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 1998; 135: 319–23.CrossRefGoogle ScholarPubMed
9 Jorde, R, Sneve, M, Figenschau, Y, Svartberg, J, Waterloo, K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008; 264: 599609.CrossRefGoogle ScholarPubMed
10 Vieth, R, Kimball, S, Hu, A, Walfish, PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 2004; 3: 8.CrossRefGoogle ScholarPubMed
11 Sanders, KM, Stuart, AL, Williamson, EJ, Jacka, FN, Dodd, S, Nicholson, G, et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry 2011; 198: 357–64.CrossRefGoogle ScholarPubMed
12 Walker, JG, Mackinnon, AJ, Batterham, P, Jorm, AF, Hickie, I, McCarthy, A, et al. Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial. Br J Psychiatry 2010; 197: 4554.CrossRefGoogle ScholarPubMed
13 Bauer, M, Glenn, T, Alda, M, Andreassen, OA, Ardau, R, Bellivier, F, et al. Impact of sunlight on the age of onset of bipolar disorder. Bipolar Disord 2012; 14: 654–63.CrossRefGoogle ScholarPubMed
14 Pasco, JA, Nicholson, GC, Williams, LJ, Jacka, FN, Henry, MJ, Kotowicz, MA, et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 2010; 197: 372–7.CrossRefGoogle ScholarPubMed
15 Jacka, FN, Pasco, JA, Mykletun, A, Williams, LJ, Hodge, AM, O'Reilly, SL, et al. Association between western and traditional diets and depression and anxiety in women. Am J Psychiatry 2010; 167: 305.11.CrossRefGoogle ScholarPubMed
16 Sanchez-Villegas, A, Delgado-Rodriguez, M, Alonso, A, Schlatter, J, Lahortiga, F, Majem, LS, et al. Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry 2009; 66: 1090–8.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.
You have Access

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Preventive strategies in depression: gathering evidence for risk factors and potential interventions
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Preventive strategies in depression: gathering evidence for risk factors and potential interventions
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Preventive strategies in depression: gathering evidence for risk factors and potential interventions
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *